GSK increases stake in its publicly-listed Consumer Healthcare subsidiary in India to 72.5 per cent

GlaxoSmithKline plc (LSE: GSK) announced today that, pursuant to the voluntary open offer undertaken by its subsidiary, GlaxoSmithKline Pte. Ltd, GSK has successfully increased its stake in GlaxoSmithKline Consumer Healthcare Ltd, its publicly-listed Consumer Healthcare subsidiary in India, from 43.2% to 72.5%

Source: GSK news - February 5, 2013 Category: Pharmaceuticals Source Type: news